
PERRIGO CO PLC
PRGONYSETrading Snapshot
- Day Range
- $12.29 β $12.53
- 52-Week Range
- $9.23 β $24.61
- Volume
- $2.00B
- Avg Volume
- $1.35B
- Shares Outstanding
- 138.4M
- Next Earnings
- Sep 25, 2026
Fundamentals Snapshot
- Annual Revenue
- $4.25B
- Last Q Revenue
- $1.02B
- P/E Ratio
- β
- P/S Ratio
- 0.4x
- EPS (TTM)
- $-12.59
- Dividend Yield
- 9.27%
Why Investors Own PRGO
- βHigh-growth profile β revenue up +53.7% YoY with expanding US Equity exposure.
- βHealthy economics β 79% gross margin and 6% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About PERRIGO CO PLC
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; womenβs health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
PERRIGO CO PLC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift PRGO price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
PERRIGO CO PLC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.